PROBABILITY OF PK/PD TARGET ATTAINMENT (PTA) FOR ASIAN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA (CAP) TREATED WITH CEFTAROLINE FOSAMIL (CPT-F).

被引：0
|
作者：
Li, J. [1 ]
Melnick, D. A. [2 ]
Ambler, J. [1 ]
机构：
[1] AstraZeneca LP, Waltham, MA USA
[2] AstraZeneca LP, Wilmington, DE USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2015年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-079
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 23 条
  • [1] Population Pharmacokinetic Modeling and Probability of Target Attainment Analyses in Asian Patients With Community-Acquired Pneumonia Treated With Ceftaroline Fosamil
    Li, Jianguo
    Das, Shampa
    Zhou, Diansong
    Al-Huniti, Nidal
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (05): : 682 - 694
  • [2] A Retrospective Analysis of Probability of Target Attainment in Community-Acquired Pneumonia: Ceftaroline Fosamil Versus Comparators
    Cristinacce, Andrew
    Wright, James G.
    Stone, Gregory G.
    Hammond, Jennifer
    McFadyen, Lynn
    Raber, Susan
    [J]. INFECTIOUS DISEASES AND THERAPY, 2019, 8 (02) : 185 - 198
  • [3] A Retrospective Analysis of Probability of Target Attainment in Community-Acquired Pneumonia: Ceftaroline Fosamil Versus Comparators
    Andrew Cristinacce
    James G. Wright
    Gregory G. Stone
    Jennifer Hammond
    Lynn McFadyen
    Susan Raber
    [J]. Infectious Diseases and Therapy, 2019, 8 : 185 - 198
  • [4] Integrated Safety Summary Of Ceftaroline Fosamil (CPT): Safety In Patients Overall And For Patients With Community-Acquired Pneumonia (CAP)
    Rank, D. R.
    Friedland, H. D.
    Eckburg, P. B.
    Smith, A.
    Thye, D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [5] Population PK Modeling and Target Attainment Simulations to Support Dosing of Ceftaroline Fosamil in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia
    Riccobene, Todd A.
    Khariton, Tatiana
    Knebel, William
    Das, Shampa
    Li, James
    Jandourek, Alena
    Carrothers, Timothy J.
    Bradley, John S.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (03): : 345 - 355
  • [6] Pharmacokinetic-Pharmacodynamic Analyses for Efficacy of Ceftaroline Fosamil in Patients with Community-Acquired Bacterial Pneumonia
    Bhavnani, Sujata M.
    Hammel, Jeffrey P.
    Van Wart, Scott A.
    Rubino, Christopher M.
    Reynolds, Daniel K.
    Forrest, Alan
    Khariton, Tatiana
    Friedland, H. David
    Riccobene, Todd A.
    Ambrose, Paul G.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (12) : 6348 - 6350
  • [7] Ceftaroline fosamil for treating skin and skin structure infections or community-acquired pneumonia in patients with renal insufficiency
    Maggiore, Christy
    Pasquale, Timothy
    Cole, Phillip
    Friedland, H. David
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (01) : 141 - 153
  • [8] EFFICACY OF CEFTAROLINE FOSAMIL AND OTHER INTRAVENOUS ANTIBIOTICS IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA (CAP): A NETWORK META-ANALYSIS (NMA)
    Medic, G.
    Karabis, A.
    Borrill, J.
    Worrall, J.
    Bergman, G.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A385 - A385
  • [9] ECONOMIC EFFECTIVENESS OF CEFTAROLINE FOSAMIL FOR THE TREATMENT OF HOSPITALISED PATIENTS WITH PNEUMOCOCCAL COMMUNITY-ACQUIRED PNEUMONIA FROM A SOCIETAL PERSPECTIVE
    Belkova, Y. A.
    Rachina, S. A.
    Kozlov, R. S.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A237 - A237
  • [10] Population pharmacokinetic (PPK) analysis of ceftaroline (CPT) in patients with complicated skin and skin structure infection (cSSSI) or community-acquired pneumonia (CAP).
    Van Wart, Scott A.
    Forrest, Alan
    Khariton, Tatiana
    Rubino, Christopher M.
    Bhavnani, Sujata M.
    Riccobene, Todd
    Ambrose, Paul G.
    [J]. PHARMACOTHERAPY, 2012, 32 (10): : E211 - E212
123